Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors
about
Semaphorin-4A, an activator for T-cell-mediated immunity, suppresses angiogenesis via Plexin-D1Keystone symposium: the role of microenvironment in tumor induction and progression, Banff, Canada, 5-10 February 2005Molecular underpinnings of corneal angiogenesis: advances over the past decadeCapillary sprout endothelial cells exhibit a CD36 low phenotype: regulation by shear stress and vascular endothelial growth factor-induced mechanism for attenuating anti-proliferative thrombospondin-1 signalingVicrostatin - an anti-invasive multi-integrin targeting chimeric disintegrin with tumor anti-angiogenic and pro-apoptotic activitiesMatrix metalloproteinases and the regulation of tissue remodellingAn antiangiogenic neurokinin-B/thromboxane A2 regulatory axisLack of collagen XVIII/endostatin exacerbates immune-mediated glomerulonephritis.Hypothesis: primary antiangiogenic method proposed to treat early stage breast cancerTargeting the tumor microenvironment.Short pigment epithelial-derived factor-derived peptide inhibits angiogenesis and tumor growth.NF-kappaB balances vascular regression and angiogenesis via chromatin remodeling and NFAT displacement.Tamoxifen and flaxseed alter angiogenesis regulators in normal human breast tissue in vivo.DNA methylation profile distinguishes clear cell sarcoma of the kidney from other pediatric renal tumorsReduction of tumstatin in asthmatic airways contributes to angiogenesis, inflammation, and hyperresponsiveness.Counterbalancing angiogenic regulatory factors control the rate of cancer progression and survival in a stage-specific manner.Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch.Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis)Proteolytically Derived Endogenous Angioinhibitors Originating from the Extracellular MatrixTumor stroma derived biomarkers in cancer.Endostatin lowers blood pressure via nitric oxide and prevents hypertension associated with VEGF inhibition.Thrombospondin-1 inhibits VEGF levels in the ovary directly by binding and internalization via the low density lipoprotein receptor-related protein-1 (LRP-1).The clinical potential of antiangiogenic fragments of extracellular matrix proteinsStructural basis for the functions of endogenous angiogenesis inhibitors.Endostatin and endorepellin: A common route of action for similar angiostatic cancer avengersCD47-retargeted oncolytic adenovirus armed with melanoma differentiation-associated gene-7/interleukin-24 suppresses in vivo leukemia cell growthBone marrow-derived Gr1+ cells can generate a metastasis-resistant microenvironment via induced secretion of thrombospondin-1.A phase II, randomized, double-blind, placebo-controlled multicenter trial of Endostar in patients with metastatic melanoma.Type IV collagen is a tumour stroma-derived biomarker for pancreas cancerAcrolein: unwanted side product or contribution to antiangiogenic properties of metronomic cyclophosphamide therapy?Combination of antiangiogenesis with chemotherapy for more effective cancer treatment.Constitutive expression of IL-12R beta 2 on human multiple myeloma cells delineates a novel therapeutic target.Signaling mechanisms of endogenous angiogenesis inhibitors derived from type IV collagen.Novel aspects of corneal angiogenic and lymphangiogenic privilege.Vector-mediated Tum-5 expression in neovascular endothelial cells for treating hepatocellular carcinoma.Antiangiogenic anticancer strategy based on nanoparticulate systems.COL4A1 and COL4A2 mutations and disease: insights into pathogenic mechanisms and potential therapeutic targets.Vascular endothelial growth factor trap-eye and trap technology: Aflibercept from bench to bedside.EG-VEGF, BV8, and their receptor expression in human bronchi and their modification in cystic fibrosis: Impact of CFTR mutation (delF508).Degraded iota-carrageenan can induce apoptosis in human osteosarcoma cells via the Wnt/β-catenin signaling pathway.
P2860
Q24298191-F32F4F7A-10F7-43ED-8A2B-88F68DB6AE86Q24810275-29ED28F4-DC2D-476F-B7EC-027202C562A7Q26747539-B29C1621-04B5-47A8-87B0-A38BD65CCF56Q28581719-55DC1D64-8051-48A4-8068-CCA648DD1F24Q28751757-656253BC-611F-4258-89BF-4A3F49CD2FD3Q29618747-7CA1F831-670D-4536-90D9-1910220737C5Q30480495-3BD766CF-D4BA-4EE8-9C13-CCC2A12B9BDEQ30497785-968D8C73-78F3-4D80-AF66-E3797DCA981FQ33398689-FC5495A7-623A-4B54-8D00-92BD1997119CQ33736691-5722FEB1-635A-436A-A4C7-2E302DDE4FCEQ33789026-2CCB4AA0-ADB6-47FB-9460-2348A6878892Q34033879-3CAF7FF3-FDF1-4C25-B556-5015764062EEQ34044998-6690E9FD-1683-43A9-B361-5F075695B28EQ34701105-EB3294C6-5B66-43DA-A30A-9A3AE3265D16Q35010424-05C8F40B-352A-4094-A661-BBFB12BBAD2FQ35049228-B1A4ED8F-2341-4A97-AAA8-4B81CB7D4A11Q35133764-A9772D6E-FBBF-4DA4-AE97-F7D1B1360563Q35662667-0F8E3C73-D2BE-461F-8F7A-17D713F37AD9Q35679807-D3F53E71-AA73-42A4-BC60-7F89406378C1Q35765454-204817AE-CAC6-4EA4-9EEE-0D5A3D578C92Q36094099-D492F177-51EC-45FE-BEAA-AC036E7EE949Q36140753-F7A07BB2-0ACB-4D4A-8775-A95D3F88E064Q36290509-300A41AB-F455-49A0-B572-388197FA56F6Q36547755-6A29BD9F-375E-49B0-A4D2-D3990ED4ABD8Q36578668-AD3FA300-FC44-43B7-B697-B42E02AB30E3Q36685435-86053E17-5E65-43B8-BF22-746E458F2E75Q36902175-29685AB2-A8E8-4852-90ED-61765F78477FQ36984477-AEFF3006-B8F6-4B50-9E51-B629747BA9B9Q37269683-DA1A4D16-58FF-448C-A8E2-3FB4BF05CE02Q37310699-6A54A4A4-38CF-4548-BD87-48D1BB9A958FQ37346912-538C6CED-383B-47B0-808F-A15FFA4A682AQ37351173-4F853F6E-63FD-4279-84C5-92F5F195A4A8Q37380604-4C058D02-FE31-4955-97AD-C64342E4CC60Q37681157-E28D1518-A6B5-4C17-94B6-E022521BD4EFQ37734962-E2D901A6-6834-469F-93B3-C35E06A18C75Q37876400-C0AC57E1-CDA8-4903-88A8-E82542CA05CBQ38036904-988C7333-D406-49EA-B3F8-CFA19F325E96Q38266022-90C9EC15-3D10-4320-984E-7A4AD2835DBFQ38866990-026E187D-A8B9-4E58-A5CD-41FA7472787BQ39201605-9DF508AA-9CA7-45C5-B8DA-FD22E9875E3A
P2860
Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Function of endogenous inhibit ...... ium-specific tumor suppressors
@ast
Function of endogenous inhibit ...... ium-specific tumor suppressors
@en
type
label
Function of endogenous inhibit ...... ium-specific tumor suppressors
@ast
Function of endogenous inhibit ...... ium-specific tumor suppressors
@en
prefLabel
Function of endogenous inhibit ...... ium-specific tumor suppressors
@ast
Function of endogenous inhibit ...... ium-specific tumor suppressors
@en
P2093
P2860
P50
P356
P1476
Function of endogenous inhibit ...... ium-specific tumor suppressors
@en
P2093
Akulapalli Sudhakar
Amish Shah
Hikaru Sugimoto
Jack Lawler
Laura E Benjamin
Mary Soubasakos
Udaya Yerramalla
Yuki Hamano
P2860
P304
P356
10.1073/PNAS.0500180102
P407
P577
2005-02-14T00:00:00Z